Company profile

Endotelix Diagnostics Sàrl

Endotelix is a spin-off from the University of Geneva and dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome including diagnostic tests and treatment options. We are currently developing a new diagnostic test to measure the circulating levels of antiphospholipid antibodies (aPL) as a rapid test (LFA-like). It allows the measuring of anti-ß2GP1 IgG and IgM. This diagnostic test is more sensitive and faster than the current assays. We have also developed an ELISA test for hospital and Research Use Only.

Highlights

Winner Venture KickWinner Venture Kick

More news about Endotelix Diagnostics Sàrl

16.03.2023 09:00

FIF Funding for three new Geneva projects

Please login or
register to use the
awards follow feature
03.06.2019 15:25

Die Gewinner der Swissbiolabs Challenge stehen fest

Please login or
register to use the
awards follow feature
Endotelix Diagnostics Sàrl

Founded
2019

Kanton
GE


LinkedIn

Homepage

rss